Exciting partnership announcement!

We are thrilled to unveil our partnership with Perceptive Inc. in the launch of Clinphone 5, a cutting-edge Randomization and Trial Supply Management (RTSM) platform!

This collaboration combines Perceptive’s 30+ years of RTSM industry-leading expertise with our next-generation technology, creating an innovative cloud-native, multi-tenant solution that is set to provide agility, adaptability and scalability.

As our CEO, Stanley Kim, put it:

"This collaboration has allowed us to integrate their unparalleled industry knowledge with our technological capabilities. I believe Clinphone 5 will only be the beginning and that this platform will continue to evolve and redefine what’s possible in RTSM."

We’re incredibly proud of what this partnership has accomplished, and we’re even more excited about the future. We're not just evolving clinical research technology — we’re transforming it.

Read the press release: https://www.prnewswire.com/news-releases/perceptive-eclinical-launches-clinphone-5-a-ground-breaking-new-rtsm-platform-delivering-a-leap-in-clinical-development-technology-302301627.html

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

A discussion with Stanley Kim and Rob Robertson

Although both CRScube and Mednet were built in different environments, there is a strong sense of culture and belonging at their core.

Beyond the data: Human stories from clinical trials in Ukraine

From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, Anna paints a vivid picture of resilience and resourcefulness under pressure.

Why Mednet. Why Now.

CRScube and Mednet are a natural fit. We are both innovators in eClinical technology. We both operate on a SaaS model, serve the same customers, and believe in transforming clinical trials.